Vimarsana
Biggest News Aggregation in the World

Asthma Immunol News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Asthma Immunol. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Asthma Immunol Today - Breaking & Trending Today

Obesity Linked to Atopic Dermatitis Severity, Pathophysiological Data Gaps Remain - Vimarsana News

Obesity Linked to Atopic Dermatitis Severity, Pathophysiological Data Gaps Remain

This observational cohort study looked at the link between obesity and eczema, highlighting regional differences in the skin disease and obesity’s interdependence.

Urticaria: The Itchy Reality You Never Knew About! - Vimarsana News

Urticaria: The Itchy Reality You Never Knew About!

What is Urticaria? "My hands are currently swollen and covered in raised bumps, making it difficult for me to close them completely” "I couldn’t sleep at night, my whole body was so itchy.” "Why are there raised bumps on my hands?” Have you ever been in a similar situation? Well, If you have been experiencing sudden itching, raised welts or bumps on your skin, it is possible that you may have been dealing with a condition called Urticaria?  Urticaria, also known as hives, is a skin condition characterised by the development o...

First patients dosed in Phase III trials evaluating Fasenra in hypereosinophilic syndrome, eosinophilic esophagitis and eosinophilic granulomatosis - Vimarsana News

First patients dosed in Phase III trials evaluating Fasenra in hypereosinophilic syndrome, eosinophilic esophagitis and eosinophilic granulomatosis

Search jobs 16-Dec-2020 First patients dosed in Phase III trials evaluating Fasenra in hypereosinophilic syndrome, eosinophilic esophagitis and eosinophilic granulomatosis with polyangiitis New clinical trial also announced for Fasenra in eosinophilic gastritis/eosinophilic gastroenteritis The first patients have been dosed in Fasenra (benralizumab) Phase III trials in three rare eosinophilic diseases: hypereosinophilic syndrome (HES), eosinophilic esophagitis (EoE) and eosinophilic granulomatosis with polyangiitis (EGPA) AstraZeneca will al...